BCL2 and cancer: Cancer cells show resistance to apoptosis mediated by over expression of oncogenic genes (such as c-Myc, which enhances cellular proliferation and suppresses p53), and anti-apoptotic proteins (Bcl-2, survivin, livin, etc.)[9].